Integrity Retractable Implant Inserter (6000127)
Anika Therapeutics, Inc. · Decision date Sep 17, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 17, 2026 for K261869, the Integrity Retractable Implant Inserter (6000127) submitted by Anika Therapeutics, Inc. of Bedford, Massachusetts. The submission is a Traditional 510(k) under 21 CFR 888.3040, Class II, product code MBI, orthopedic specialty. SESE means clearance to market, not premarket approval. The device is a sterile, single-use inserter that delivers a polyetheretherketone bone staple to fix the Integrity Implant to bone during rotator cuff repair, described in the summary as a line extension of the instruments in the Integrity Bone Staple Fixation System, cleared as K223860 on May 22, 2023.
The summary states non-clinical biocompatibility and mechanical performance testing supported substantial equivalence, with endotoxin testing under USP <85>, and that clinical testing was deemed unnecessary. The indications text in the enclosure concerns the Integrity Bone Staple Fixation System for fixation of soft tissue grafts or reinforcement meshes to bone during rotator cuff repairs. The record does not resolve discrepancies in the source, including differing received dates (June 4 versus August 13, 2026) and the regulation name given in the letter.
The record does not state whether the inserter itself carries a separate indication or how it is labeled for reuse, and no clinical outcome data are presented.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 17, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261869
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Anika Therapeutics, Inc.
- Product code
- MBI
- Decision code
- SESE
- Decision date
- Sep 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Fastener, Fixation, Nondegradable, Soft Tissue.
- Applicant
- Anika Therapeutics, Inc.
- Product code
- MBI
- FDA device class
- 2
FDA decision timeline
K261869 received
Application receipt date recorded by FDA.
K261869 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MBI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Arthrex FiberButtonK263477 | ARTHREX, INC. | 510(k) clearance | Oct 27, 2026 | FDA |
| Smith & Nephew, Inc. | 510(k) clearance | Oct 23, 2026 | FDA | |
TeKBrace Knotless AnchorK263352 | TheraMicro | 510(k) clearance | Oct 21, 2026 | FDA |
| Aevumed, Inc. | 510(k) clearance | Sep 2, 2026 | FDA | |
ArthroTAK Tendon Anchor KitK262809 | ArthroTAK, LLC | 510(k) clearance | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Anika Therapeutics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Beford, MA
Sources and methodology
- Original FDA record: K261869
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



